Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Immunotherapy of sarcoma
Sandra P. D'Angelo
*
,
Seth M. Pollack
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Book/Report
›
Book
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Immunotherapy of sarcoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Sarcoma
100%
Immunotherapy
62%
Development
25%
Combination Therapy
25%
Cytokine Therapy
25%
Cancer Immunology
25%
Clinical Research
25%
Patient
25%
Tumor Immunology
25%
Neoplasm
12%
Vaccine
12%
Solid Malignant Neoplasm
12%
Microenvironment
12%
Natural Killer Cell
12%
Attention
12%
Analysis
12%
Laboratory
12%
Inpatient
12%
Therapeutic Procedure
12%
Comprehension
12%
Cancer
12%
T Cell
12%
Reading
12%
Oncologist
12%
INIS
sarcomas
100%
immunotherapy
62%
patients
37%
tumors
37%
therapy
37%
immunology
25%
laboratories
12%
cancer
12%
solids
12%
information
12%
cytokines
12%
toxicity
12%
metastases
12%
malignancies
12%
natural killer cells
12%
medical personnel
12%
vaccines
12%
Pharmacology, Toxicology and Pharmaceutical Science
Sarcoma
100%
Immunotherapy
62%
Neoplasm
12%
Solid Malignant Neoplasm
12%
Vaccine
12%
Immunology and Microbiology
Immunotherapy
62%
Development
25%
Natural Killer Cell
12%
Electric Potential
12%
Solid
12%
Vaccine Therapy
12%
Comprehension
12%
Immunity
12%
Attention
12%